Here's the live share price of Hamps Bio along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Hamps Bio has declined 13.94% CAGR. Over the past year, the corresponding return has been -52.80%.
Hamps Bio’s current P/E of -129.09x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Hamps Bio | -2 | 4.71 | -8.17 | 5.98 | -52.8 | -22.14 | -13.94 |
| Sun Pharmaceutical Industries | -1.43 | 7.07 | 13.19 | 7.23 | -0.26 | 20.27 | 25.39 |
| Divi's Laboratories | -0.17 | -6.07 | 7.63 | -2.44 | 6.11 | 24.3 | 11.72 |
| Torrent Pharmaceuticals | 1.4 | 6.17 | 5.41 | 20.03 | 12.21 | 32.61 | 22.92 |
| Cipla | -0.68 | 1.37 | -2.11 | 2.07 | 1.44 | 10.88 | 14.51 |
| Dr. Reddy's Laboratories | 1.46 | 5.93 | 0.63 | -1.03 | 2.93 | 12.53 | 4.9 |
| Lupin | 0.8 | 7.24 | 7.87 | 5.13 | -1.31 | 39.66 | 16.74 |
| Zydus Lifesciences | -0.97 | -0.34 | -7.99 | -2.35 | -4.61 | 31.21 | 14.6 |
| Mankind Pharma | -2.14 | -4.58 | -13.64 | -6.68 | -15.87 | 15.66 | 9.12 |
| Aurobindo Pharma | -0.7 | 6.56 | 16.37 | 4.82 | -2.28 | 37.65 | 5.94 |
| Alkem Laboratories | 0.31 | 1.03 | 6.85 | 17.8 | 1 | 22.31 | 14.31 |
| Abbott India | -4.03 | -2.11 | -7.45 | -8.97 | -0.57 | 12.89 | 13.55 |
| Glenmark Pharmaceuticals | 0.95 | 8.56 | -4.27 | 24.01 | 27.25 | 65.25 | 29.86 |
| Laurus Labs | -0.52 | 4.81 | 16.45 | 60.15 | 74.45 | 34.62 | 25.34 |
| Biocon | -1.36 | 2.03 | 7.97 | 18.8 | 4.77 | 12.07 | -2.7 |
| GlaxoSmithKline Pharmaceuticals | -0.8 | -2.18 | -8.1 | -26.41 | 7.11 | 23.85 | 10.42 |
| Anthem Biosciences | 2.91 | -6.16 | -21.24 | -10.52 | -10.52 | -3.64 | -2.2 |
| Ipca Laboratories | -0.89 | 10.58 | 7.86 | 3.84 | -3.67 | 18.6 | 5.37 |
| Ajanta Pharma | 2.62 | 2.13 | 0.39 | 1.85 | -10.03 | 27.61 | 18.58 |
| Gland Pharma | -0.53 | -7.82 | -7.58 | 7.36 | -4.51 | -0.01 | -5.73 |
Over the last one year, Hamps Bio has declined 52.80% compared to peers like Sun Pharmaceutical Industries (-0.26%), Divi's Laboratories (6.11%), Torrent Pharmaceuticals (12.21%). From a 5 year perspective, Hamps Bio has underperformed peers relative to Sun Pharmaceutical Industries (25.39%) and Divi's Laboratories (11.72%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 25.29 | 24.89 |
| 10 | 24.53 | 24.43 |
| 20 | 22.97 | 23.99 |
| 50 | 25.29 | 24.25 |
| 100 | 23.65 | 25.43 |
| 200 | 21.95 | 0 |
In the latest quarter, Hamps Bio remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 28.01% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 25, 2025, 11:39 PM IST | Hamps Bio - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Nov 25, 2025, 12:06 AM IST | Hamps Bio - Shareholder Meeting / Postal Ballot-Outcome of EGM |
| Nov 15, 2025, 12:56 AM IST | Hamps Bio - Unaudited Financial Results For The Half Year Ended 30.09.2025. |
| Nov 15, 2025, 12:44 AM IST | Hamps Bio - Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results For The Half Year End |
| Nov 14, 2025, 12:50 AM IST | Hamps Bio - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Half Year Ended Se |
Hamps Bio Ltd. is a Public Limited Listed company incorporated on 02/01/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24233GJ2007PLC049692 and registration number is 049692. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 6.67 Cr. and Equity Capital is Rs. 4.36 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hamps Bio is ₹24.01 as on Dec 05, 2025.
The Hamps Bio is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Hamps Bio is ₹20.92 Cr as on Dec 05, 2025.
Today’s highest and lowest price of Hamps Bio are ₹24.01 and ₹24.01.
The 52-week high/low is the highest and lowest price at which Hamps Bio stock has traded in the past 52-week or nearly a year. The 52-week high of Hamps Bio is ₹0.00 and 52-week low of Hamps Bio is ₹0.00 as on Dec 05, 2025.
The Hamps Bio has shown returns of -2.0% over the past day, 4.71% for the past month, -8.17% over 3 months, -52.8% over 1 year, -22.14% across 3 years, and -13.94% over 5 years.
P/E ratio of and PB ratio of Hamps Bio are -129.09 and 2.38 on Dec 05, 2025. While the company gives a dividend yield of 0.00 per annum.